The Inspire ANTI SNORING Implant is a medical device that’s implanted into the body for the treatment of snoring and obstructive anti snoring (OSA) syndrome.
Obstructive Sleep Apnea Syndrome
Obstructive anti snoring syndrome is a disease due to relapsing episodes of sleep apnea. It is a condition where breathing stops for more than 10 seconds, where oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs while asleep, once the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This results in deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places pressure on the body, causing increased blood circulation pressure and development of severe diseases. The diseases due to OSA can be physical, such as hypertension, myocardium infarction and stroke. ufabet They might also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is needed. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severe nature of the disease. The apnea index is known as significant if you can find more than 20 apnea episodes each hour, whatever the presence or absence of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many folks find it uncomfortable to sleep with the mask on the face and the device itself could be loud, especially since it commonly sits near the head. Only 25% of patients may use CPAP-therapy for an extended period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire ANTI SNORING Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately 10 years.
The main unit of this device is placed beneath the skin, on leading right side of the chest also it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens the upper airways and allows the tongue to stand out, and helps keep the airways open while asleep.
In addition to the two electrodes, this product also includes a handy small remote switch, that actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of your day, when a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The individual may feel light involuntary contractions of the larynx, or tongue movements during initial use of the device. These movements do not cause pain, instead just a minor discomfort. These unpleasant effects disappear after the first few uses of these devices.
Generally, the implant should be checked 1 or 2 2 times per year. However, based on the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire ANTI SNORING Implant is only suitable for:
Patients who are a lot more than 22 years old.
Patients who have been diagnosed with moderate or severe obstructive anti snoring syndrome.
Patients with an apnea index in the number of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or did not have the desired effect.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. shows that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at 24 months following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly usage of this therapy for five years. Therefore, it really is evident that method is impressive and simple to use!
Categories:
No Responses